Alacrita Medical Imaging Consultant Presenting at International Osteoarthritis Conference

Tuesday, April 25, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

CAMBRIDGE, Massachusetts, April 25, 2017 /PRNewswire/ --

Alacrita, the life sciences consulting firm, today announced

that medical imaging expert and Alacrita Partner, Colin G Miller PhD, will present a poster at the upcoming Osteoarthritis Research Society International (OARSI) Annual Meeting in Las Vegas from 27th to 30th April.


is the co-author of a poster presentation entitled, "Standardization of imaging reads for eligibility assessment of patients - Component of a risk mitigation strategy in the Tanezumab Clinical program." This has part of a major anti-Nerve Growth Factor program being conducted by Pfizer for which Colin has been consulting for over 4 years. Colin is an experienced medical imaging consultant and specializes in optimizing the use of medical imaging to evaluate the safety and efficacy of novel pharmaceuticals.

Colin will participate in the inaugural workshop in "Clinical Trials in Osteoarthritis," which is designed to equip investigators and industry sponsors with an understanding of the complexities of running patient-oriented randomized clinical trials in osteoarthritis. Colin is a member of the organizing committee and a Corporate advisor to the conference.

"The OARSI meeting is the premier meeting for preclinical and clinical research in the field of osteoarthritis," stated Colin Miller. "I have participated in OARSI for over 10 years and am delighted to accept the invitation to participate on the organizing committee for the workshop on clinical trials in osteoarthritis. The treatment of osteoarthritis represents a significant unmet medical need and there are several therapies in development for disease modification, so this workshop comes at a key time."

Rob Johnson, Managing Partner at Alacrita, said: "The Alacrita team consists of high calibre individuals to provide world-class pharma consulting services. Dr Miller has co-authored over a dozen publications in the conduct of clinical trials in osteoarthritis and the challenges of imaging endpoints, is a recognized expert in medical imaging and a respected consultant in the osteoarthritis field. This level of contribution exemplifies the Alacrita approach and that we continue to have impact in our respective areas of expertise."

About Alacrita  

Alacrita is a rapidly growing, transatlantic life science consulting firm providing expertise-based services to the pharmaceutical, biotechnology and life science sectors. The firm is supported by an unrivalled team of experts who operate across the spectrum of life sciences. They combine extensive international industry experience (product development, commercialization, business development), broad functional capabilities and a track record of success across the industry.

Media Contact: Alacrita Europe: London BioScience Innovation Centre 2 Royal College Street London, NW1 0NH Tel: +44-207-691-4915

Alacrita USA: One Broadway, 14th floor Kendall Square Cambridge, MA 02142 Tel: +1-617-714-9696

For further information, please contact: Colin G Miller, Partner

SOURCE Alacrita

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store